Search research articles
Contact Us
Filters
Showing results (21-30 of 99) with videos related to
Page
of 10
Sort By:
The American Journal of Cardiology
|
March 20, 2014
Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease
Alberto Zambon, Xue-Qiao Zhao, B Greg Brown, et al.
Journal of Hypertension
|
September 26, 2003
C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?
Marcello Rattazzi, Massimo Puato, Elisabetta Faggin, et al.
Atherosclerosis
|
August 21, 2013
Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C
Alberto Zambon, Massimo Puato, Elisabetta Faggin, et al.
Current Atherosclerosis Reports
|
October 3, 2020
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction
Alberto Zambon, Angela Pirillo, Sabina Zambon, et al.
Current Opinion in Lipidology
|
March 19, 2003
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
Alberto Zambon, Samir S Deeb, Paolo Pauletto, et al.
Atherosclerosis
|
September 14, 2007
Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population: the Italian Longitudinal Study on Aging
Stefania Maggi, Marianna Noale, Alberto Zambon, et al.
Cardiovascular Diabetology
|
April 12, 2026
Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins
Julia Brandts, Marlo Verket, Alberto Zambon, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies
Arrigo F G Cicero, Federica Fogacci, Alberto Zambon, et al.
Pharmacological Research
|
July 8, 2020
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials
Manuela Casula, Elena Olmastroni, Marta Gazzotti, et al.
Journal of Lipid Research
|
March 18, 2003
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet
Samir S Deeb, Alberto Zambon, Molly C Carr, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 99) with videos related to
Sort By:
Page
of 10
The American Journal of Cardiology
|
March 20, 2014
Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease
Alberto Zambon, Xue-Qiao Zhao, B Greg Brown, et al.
Journal of Hypertension
|
September 26, 2003
C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?
Marcello Rattazzi, Massimo Puato, Elisabetta Faggin, et al.
Atherosclerosis
|
August 21, 2013
Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C
Alberto Zambon, Massimo Puato, Elisabetta Faggin, et al.
Current Atherosclerosis Reports
|
October 3, 2020
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction
Alberto Zambon, Angela Pirillo, Sabina Zambon, et al.
Current Opinion in Lipidology
|
March 19, 2003
Hepatic lipase: a marker for cardiovascular disease risk and response to therapy
Alberto Zambon, Samir S Deeb, Paolo Pauletto, et al.
Atherosclerosis
|
September 14, 2007
Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population: the Italian Longitudinal Study on Aging
Stefania Maggi, Marianna Noale, Alberto Zambon, et al.
Cardiovascular Diabetology
|
April 12, 2026
Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins
Julia Brandts, Marlo Verket, Alberto Zambon, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
April 1, 2024
Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies
Arrigo F G Cicero, Federica Fogacci, Alberto Zambon, et al.
Pharmacological Research
|
July 8, 2020
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials
Manuela Casula, Elena Olmastroni, Marta Gazzotti, et al.
Journal of Lipid Research
|
March 18, 2003
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet
Samir S Deeb, Alberto Zambon, Molly C Carr, et al.
Page
of 10